Search results
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Zacks via Yahoo Finance· 6 hours agoVertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings...
Vertex Pharmaceuticals (VRTX) to Release Earnings on Monday
ETF DAILY NEWS· 16 hours agoVertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) will be announcing its earnings results after the market closes on Monday, May 6th. Analysts expect Vertex Pharmaceuticals ...
... $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs - Vertex...
Benzinga· 3 days agoVertex Pharmaceuticals Inc‘s VRTX blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some patients by up ...
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Zacks via Yahoo Finance· 6 days agoVertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem...
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Zacks via Yahoo Finance· 4 days agoVertex Pharmaceuticals (VRTX) closed the most recent trading day at $397.70, moving -0.76% from the...
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest By Benzinga
Investing.com· 4 days agoVertex Pharmaceuticals's (NYSE:VRTX) short percent of float has fallen 3.75% since its last report....
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 6 days agoVertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic...
2 Top Growth Stocks to Buy Right Now and Hold Forever
Motley Fool via Yahoo Finance· 1 day agoIf you're looking for top healthcare stocks to buy right now, here are two names you'll want to...
Sigma Planning Corp Sells 1,061 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 5 days agoSigma Planning Corp cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 37.3% during the 4th quarter, according to its most recent Form ...
EU expands cystic fibrosis treatment for infants with KALYDECO By Investing.com
Investing.com· 3 days agoVertex Pharmaceuticals (NASDAQ:VRTX) has announced the European Commission's approval to expand the...